111In-octreotide and 123I-MIBG scintigraphy for imaging carcinoids and its metastases: Results of a comparative investigation;111In-octreotide- und 123I-MIB G-szintigraphie in der diagnostik von dünndarmkarzinoiden: Ergebnisse einer vergleichenden untersuchung

NuklearMedizin

Volumn 35, Issue 2, 1996, Pages 53-58

  Dresel, S ^a   Tatsch, K ^a   Zachoval, R ^a   Hahn, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Carcinoids; Computed tomography (CT); MIBG scintigraphy; Octreotide scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; INDIUM 111 OCTREOTIDE; INDIUM-111-OCTREOTIDE; IODOBENZENE; OCTREOTIDE; RADIOACTIVE IODINE; INDIUM 111; IODINE 123;

ADULT; AGED; ARTICLE; CARCINOID; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; INTESTINE TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; CLINICAL ARTICLE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; CARCINOID TUMOR; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INTESTINAL NEOPLASMS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OCTREOTIDE; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029664856     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629695     Document Type: Article

References (17)

1. Adolph JMG, Kimmig BN, Georgi P. zum Winkel K. Carcinoid tumors: CT and 1-131 MIBG scintigraphy. Radiology 1987; 164: 199-203.
2. 131I-MIBG-Szintigraphie in der Diagnostik der intestinalen Karzinoide. Nucl-Med 1987; 26: 263-7.
3. Bomanji J, Ur E, Mather S et al. A scintigraphic comparison I-123 MIBG and an Iodine labeled somatostatin analogue in metastatic carcinoid tumors. J Nucl Med 1992; 33: 1121-4
4. Dörr U, Räth U, Schürmann G et al. Somatostatin-Rezeptor-Szintigraphie. Fortschr Rontgenstr 1993; 158,1: 67-73.
5. Dörr U, Rath U, Sautter-Bihl ML, Guzman G et al. Improved visualization of carcinoid liver metastases by In-111-pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med 1993; 20: 431-3.
6. Feldman JM, Blinder RA, Lucas KJ, Coleman RE. I-131 MIBG scintigraphy of carcinoid tumors. J Nucl Med 1986; 27: 1691-6.
7. Hanson MW, Feldman JM, Blinder RA, Moore JO, Coleman E. Carcinoid tumors: I-131 MIBG scintigraphy. Radiology 1989; 172: 699-703.
8. Hoefnagel CA. MIBG and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994; 21: 561-81.
9. Joseph K, Stapp J, Reinicke J et al. Receptor scintigraphy with 111-In-Pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res Suppl 1993; 27: 28-35.
10. Krenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with In-111 and I-123 octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-31.
11. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993; 20: 283-92.
12. Lamberts SWJ, Bakker WH, Reubi HC, Krenning EP. Somatostatin receptor scintigraphy in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246-9.
13. Lebtahi R, Cadiot G, Faraggi M et al. Somatostatin receptor scintigraphy with In-111 Octreoscan in gastro-entero-pancreatic endocrine tumors. Eur J Nucl Med 1993; 20: 938.
14. McCarthy SM, Stark DD, Moss AA, Goldberg HI. Computed tomography of malignant carcinoid disease. J Comput Assist Tomogr. 1984; 8: 846-50.
15. Reubi JC, Häckl WH, Lamberts SWJ. Hormone-producing gastrointestinal tumors contain a high density of Somatostatin receptors. J Clin Endocrinol Metab 1987; 65: 1127-34.
16. Tenenbaum F, Lumbroso J, Schlumberger M et al. Comparison of Radiolabeled Octreotide and MIBG Scintigraphy in malignant pheochromocytoma. J Nucl Med 1995; 36: 1-6.
17. Vinik AI, McLeod MK, Fig LM, Shapiro B, Lloyd RV, Cho K. Clincal features, diagnosis, and localisation of carcinoid tumors and their management. Gastroenterol Clin N Am 1989; 18: 865-96.